These findings identified that EDI-3 participates in the regulation of choline phospholipid metabolism in ovarian, prostate, breast, brain and other metastatic cancers by modifying the ratio of GPC to PC, and interfering with lipid metabolism and cell signaling [54]. The gene discussed is GPCPD1; the disease is metastatic malignant neoplasm.